MicroRNA-497 upregulation inhibits cell invasion and metastasis in T24 and BIU-87 bladder cancer cells

Wei,Zhiyong; Hu,Xiaofeng; Liu,Junjie; Zhu,Wenbin; Zhan,Xuemei; Sun,Shuhong

doi:10.3892/mmr.2017.6805

MicroRNA-497 upregulation inhibits cell invasion and metastasis in T24 and BIU-87 bladder cancer cells

Authors:
- Zhiyong Wei
- Xiaofeng Hu
- Junjie Liu
- Wenbin Zhu
- Xuemei Zhan
- Shuhong Sun
View Affiliations

Affiliations: Department of Pathology, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China, Department of Clinical Laboratory, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China, Department of Pathology, Chinese Medicine Hospital in Linyi City, Linyi, Shandong 276000, P.R. China, Department of Urinary Surgery, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China
Published online on: June 19, 2017 https://doi.org/10.3892/mmr.2017.6805
Pages: 2055-2060

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have reported the crucial role of microRNAs (miRNAs) in the biology and tumorigenesis of various types of cancer, including bladder cancer. The present study aimed to investigate the importance of miRNA (miR)‑497 on the pathogenesis of bladder cancer. A total of 50 patients diagnosed with bladder cancer were enrolled in the current study. The expression levels of miR‑497 in the cancerous and the adjacent noncancerous tissues were detected using reverse transcription‑quantitative polymerase chain reaction. The association between miR‑497 expression and various parameters, including age, tumor‑node‑metastasis (TNM) stage and pathological classification was determined. An miR‑497‑overexpressing vector was transfected into the T24 and BIU‑87 bladder cancer cell lines in order to determine the effect of miR‑497 expression on cell migration and invasion using Transwell assays. Additionally, the cell migration and invasion‑associated protein expression levels were also analyzed using western blotting. The findings of the present study revealed that miR‑497 was expressed at low levels in the cancer bladder tissue compared with the adjacent noncancerous tissue, and its expression was associated with the pathological classification, TNM stage and metastasis. Additionally, miR‑497 overexpression significantly reduced the number of migrated and invasive T24 and BIU‑87 cells. The mRNA and protein expression levels of E‑cadherin were increased, whereas levels of vimentin and α‑smooth muscle actin were reduced following miR‑497 overexpression. The present study revealed that miR‑497 overexpression may be a suppressor of the metastasis of bladder cancer, and may have an important role in the diagnosis of bladder cancer.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Zhang X and Zhang Y: Bladder cancer and genetic mutations. Cell Biochem Biophys. 73:65–69. 2015. View Article : Google Scholar : PubMed/NCBI
3	Harshman LC, Preston MA, Bellmunt J and Beard C: Diagnosis of bladder carcinoma: A clinician's perspective. Surg Pathol Clin. 8:677–685. 2015. View Article : Google Scholar : PubMed/NCBI
4	Cheung G, Sahai A, Billia M, Dasgupta P and Khan MS: Recent advances in the diagnosis and treatment of bladder cancer. BMC Med. 11:132013. View Article : Google Scholar : PubMed/NCBI
5	Aigner A: MicroRNAs (miRNAs) in cancer invasion and metastasis: Therapeutic approaches based on metastasis-related miRNAs. J Mol Med (Berl). 89:445–457. 2011. View Article : Google Scholar : PubMed/NCBI
6	Zheng N, Yang P, Wang Z and Zhou Q: OncomicroRNAs-mediated tumorigenesis: Implication in cancer diagnosis and targeted therapy. Curr Cancer Drug Targets. 17:40–47. 2017. View Article : Google Scholar : PubMed/NCBI
7	Medina PP and Slack FJ: MicroRNAs and cancer: An overview. Cell Cycle. 7:2485–2492. 2008. View Article : Google Scholar : PubMed/NCBI
8	Lan G, Yang L, Xie X, Peng L and Wang Y: MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer. Arch Med Sci. 11:561–569. 2015. View Article : Google Scholar : PubMed/NCBI
9	Drayton RM, Dudziec E, Peter S, Bertz S, Hartmann A, Bryant HE and Catto JW: Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11. Clin Cancer Res. 20:1990–2000. 2014. View Article : Google Scholar : PubMed/NCBI
10	Yin KJ, Deng Z, Huang H, Hamblin M, Xie C, Zhang J and Chen YE: miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 38:17–26. 2010. View Article : Google Scholar : PubMed/NCBI
11	Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang Y, Zou C, Zhang X, Liu S, Wang X, et al: Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res. 17:1722–1730. 2011. View Article : Google Scholar : PubMed/NCBI
12	Yan JJ, Zhang YN, Liao JZ, Ke KP, Chang Y, Li PY, Wang M, Lin JS and He XX: MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Oncotarget. 6:29527–29542. 2015.PubMed/NCBI
13	Zhang Y, Zhang Z, Li Z, Gong D, Zhan B, Man X and Kong C: MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3. Oncol Rep. 36:1293–1300. 2016.PubMed/NCBI
14	Du M, Shi D, Lin Y, Yuan L, Li P, Chu H, Qin C, Yin C, Zhang Z and Wang M: Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep. 5:104372015. View Article : Google Scholar : PubMed/NCBI
15	Mostofi FK, Davis CJ and Sesterhenn IA: WHO histological typing of urinary bladder tumors. Springer; Berlin: 1973
16	Union for International Cancer Control (UICC), . TNM Classification of Malignant Tumours. Sobin LH and Wittekind CH: 6th. John Wiley & Sons; Hoboken, NJ: 2002
17	Brackenbury WJ and Djamgoz MB: Nerve growth factor enhances voltage-gated Na+ channel activity and transwell migration in Mat-LyLu rat prostate cancer cell line. J Cell Physiol. 210:602–608. 2007. View Article : Google Scholar : PubMed/NCBI
18	Lin Y, Yue B, Xiang H, Liu Y, Ma X and Chen B: Survivin is expressed in degenerated nucleus pulposus cells and is involved in proliferation and the prevention of apoptosis in vitro. Mol Med Rep. 13:1026–1032. 2016.PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Yan JJ, Zhang YN, Liao JZ, Ke KP, Chang Y, Li PY, Wang M, Lin JS and He XX: MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Oncotarget. 6:29527–29542. 2015.PubMed/NCBI
21	Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang B, Shu Y and Liu P: miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol. 29:384–391. 2012. View Article : Google Scholar : PubMed/NCBI
22	Ruan WD, Wang P, Feng S, Xue Y and Zhang B: MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells. Onco Targets Ther. 9:303–313. 2016. View Article : Google Scholar : PubMed/NCBI
23	Luo Q, Li X, Gao Y, Long Y, Chen L, Huang Y and Fang L: MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer. Cancer Cell Int. 13:952013. View Article : Google Scholar : PubMed/NCBI
24	Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, et al: Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene. 30:457–470. 2011. View Article : Google Scholar : PubMed/NCBI
25	McInroy L and Määttä A: Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun. 360:109–114. 2007. View Article : Google Scholar : PubMed/NCBI
26	Peng RY, Zhou GH and Chun LI: Expression of E-cadherin in Bladder Cancer. Prac J Cancer. 15:87–88. 2000.
27	Kumar CC, Kim JH, Bushel P, Armstrong L and Catino JJ: Activation of smooth muscle alpha-actin promoter in ras-transformed cells by treatments with antimitotic agents: Correlation with stimulation of SRF:SRE mediated gene transcription. J Biochem. 118:1285–1292. 1995. View Article : Google Scholar : PubMed/NCBI
28	Kojc N, Zidar N, Vodopivec B and Gale N: Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx. Hum Pathol. 36:16–21. 2005. View Article : Google Scholar : PubMed/NCBI
29	Duan LJ, Qi J, Kong XJ, Huang T, Qian XQ, Xu D, Liang JH and Kang J: miR-133 modulates TGF-β1-induced bladder smooth muscle cell hypertrophic and fibrotic response: Implication for a role of microRNA in bladder wall remodeling caused by bladder outlet obstruction. Cell Signal. 27:215–227. 2015. View Article : Google Scholar : PubMed/NCBI
30	Zhang M, Shan LP and Zhang H: Expression of Snail and E-cadherin in bladder urothelial carcinoma and their relation with tumor recurrence. J Mod Oncol. 18:2422–2425. 2010.
31	Lewis SA, Traub P and Spilker CM: The N-terminal domain of vimentin alters bladder permeability. J Urol. 170:2091–2094. 2003. View Article : Google Scholar : PubMed/NCBI